drugset / Trial / NCT03399318

Aggressive Antipyretics for Fever Reduction in CNS Malaria

NCT03399318 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The study will examine whether prophylactic and scheduled treatment with acetaminophen and ibuprofen can decrease the maximum temperature experienced during the acute illness in children with CNS malaria.

Timeline

Start
2019-01-07
Primary completion
2022-12-02
Completion
2022-12-02

Outcome

Met primary endpoint

registry MEAN Aggressive Antipyretics (AA): 38.6 (38.4 to 38.7) degrees of Celsius MEAN Usual Care (UC).: 39.2 (39.1 to 39.3) degrees of Celsius NCT03399318 ↗

registry analysis (superiority test); Aggressive Antipyretics (AA) vs Usual Care (UC).; p <0.0001; t-test, 2 sided; NCT03399318 ↗

registry COUNT_OF_PARTICIPANTS Aggressive Antipyretics (AA): Multiple or Prolonged: 10 Participants COUNT_OF_PARTICIPANTS Usual Care (UC).: Multiple or Prolonged: 34 Participants NCT03399318 ↗

registry analysis (superiority test); Aggressive Antipyretics (AA) vs Usual Care (UC).; p <0.05; Odds Ratio (OR) 0.09 (95% CI .03 to .27); Regression, Logistic NCT03399318 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 15 mg/kg Oral
Subject Ibuprofen Small molecule 10 mg/kg Oral